FDA-Device2013-05-01Class III
Sirtex SIR-yttrium 90 microspheres (Radionuclide); SIR-Y001. Indicated for the treatment of unresectable metastatic liver tumors.
Sirtex Medical Limited
Hazard
Incorrect expiration date
Sold states
Nationwide Distribution-USA (nationwide) including DC and the states of AZ, CA, CT, GA, ID, IL,KY, LA, MD, ME, MO, MT, NJ, NV, WA, and WV.
Affected count
21 doses
Manufactured in
Centrecourt Business Park,, Unit D4, 25-27, Paul Street North, North Ryde, New South Wales, Australia
Products
Sirtex SIR-yttrium 90 microspheres (Radionuclide); SIR-Y001. Indicated for the treatment of unresectable metastatic liver tumors.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1162-2013Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief